Global Continuous Glucose Monitoring Systems Market Growth and Forecast Report 2014–2021

Allied Market Research has recently published a detailed report to compile the market information generated for the global continuous glucose monitoring systems market. The report provides the qualitative and quantitative data to specify vital market indicators such as market size, share, trends, growth, and forecasts. According to the projections made within the scope of the study, the global market is estimated to generate revenue worth $2,930 million by the end of 2021. Analysts estimate the net CAGR for the industry to be around 31.3% over the forecast period 2015–2021.

View Detail Summary of this report: https://www.alliedmarketresearch.com/global-continuous-glucose-monitoring-systems-market

The global continuous glucose monitoring systems market report takes an account of the different market segments by components, end-users, customer segments, and geographical regions to build a deeper understanding of the market structure among its readers. Based on the type of components for CGM systems, the market is divided further into transmitters, receivers, sensors, and system compatible insulin pumps. Based on end-users, the report covers glucose level testing in diagnostic centers/clinics, intensive care units, and home healthcare. Based on geographical regions, the sales and distribution can be mapped across North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, and Africa). Depending upon the type of consumer segments, the study is segmented into

The global continuous glucose monitoring systems market report highlights the sub segments that hold present and future profit potential. Considering the different system components, the CGM sensors accounted for more than 60% of the global market share in 2014. Given the current market trends, they are estimated to maintain their market dominance throughout the forecast period. Acquired market intelligence exhibits that the diagnostic centers/clinics generated the highest demand for CGM systems over the study period. Based on the geographical avenues, Europe poses as the most lucrative market segment during the analysis period. On growth charts, Asia-Pacific is expected to register the maximum growth rate during 2014–2021.

The global continuous glucose monitoring systems market report highlights the major driving and restraining factors that induce a direct impact on the industry’s growth channels. The study performs a detailed impact analysis of these factors to outline they key progressive area within the market. One of the primary driver is the rising prevalence of diabetes among global population. As per estimates, diabetes-inflicted patient group is expected to be populated by 471 million patients by 2035. This has resulted in the increased need for active management of diabetes that comes with associated cost burden. Technical progress has led to the emergence of smartphone connected CGMS, wearable CGMs and non-invasive CGMs. In addition to these, the report outlines rise in consumer awareness, latest FDA approvals, novice product launches (such as bionic pancreas), and increased product development activities as crucial driving forces for the industry.

The continuous glucose monitoring systems market report makes statistical projection to map the recent technological, economic, and business developments in this segment. Analysts have used advanced data regression tools to derive relevant figures from vast volumes of data sourced through primary and secondary market research. The study presents the findings in a comprehensible format, assisted by charts, graphs, and figures, to add clarity to the readers’ understanding.

Key findings of the CGM systems market report:

• The report indicates that North America CGM market would continue its lead in global market throughout the forecast period. The dominance is accredited to the sustained payers’ access, better affordability, and increasing confidence of CGMS among dialectologists
• The analysts indicate that the growing demand for POC/OTC continuous glucose monitoring systems would enable home healthcare to be the second-most lucrative end-user segment
• The report identifies the Gen X demographic to be highly amenable for the usage of CGM systems
• Based on growth objectives, the UK CGM market is expected to register a CAGR of 40.9% over the forecast period

The global continuous glucose monitoring systems market report presents an insider’s review to the industry through in-depth profiling of the key market players in this segment. Some of the companies that have been included in the study are Abbott, Animas, Dexcom, Glysens, Insulet, Medtronic, Omnipod, Roche, Senseonics and Yposomed. The scope of the discussion accommodates for their product portfolio, specifications, manufacturing techniques, cost & pricing structures, and financial performance as well as the business strategies. Among the popular business moves are product launches, acquisitions, mergers, collaborations, and product clearance. It cites industry instances such as the expansion of distribution and supply networks by Medtronic and Dexcom across China as strategic expansion.